AAAAAA

   
Results: 1-11 |
Results: 11
Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients
Authors: Zerr, DM Gooley, TA Yeung, L Huang, ML Carpenter, P Wade, JC Corey, L Anasetti, C
Citation: Dm. Zerr et al., Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients, CLIN INF D, 33(6), 2001, pp. 763-771
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older
Authors: Gopal, AK Gooley, TA Golden, JB Maloney, DG Bensinger, WI Petersdorf, SH Appelbaum, FR Press, OW
Citation: Ak. Gopal et al., Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older, BONE MAR TR, 27(6), 2001, pp. 593-599
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin
Authors: Linenberger, ML Hong, T Flowers, D Sievers, EL Gooley, TA Bennett, JM Berger, MS Leopold, LH Appelbaum, FR Bernstein, ID
Citation: Ml. Linenberger et al., Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin, BLOOD, 98(4), 2001, pp. 988-994
Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia
Authors: Torok-Storb, B Bolles, L Iwata, M Doney, K Sale, GE Gooley, TA Storb, R
Citation: B. Torok-storb et al., Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia, BLOOD, 98(3), 2001, pp. 891-892
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Authors: McSweeney, PA Niederwieser, D Shizuru, JA Sandmaier, BM Molina, AJ Maloney, DG Chauncey, TR Gooley, TA Hegenbart, U Nash, RA Radich, J Wagner, JL Minor, S Appelbaum, FR Bensinger, WI Bryant, E Flowers, MED Georges, GE Grumet, FC Kiem, HP Torok-Storb, B Yu, G Blume, KG Storb, RF
Citation: Pa. Mcsweeney et al., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, BLOOD, 97(11), 2001, pp. 3390-3400
Why Kaplan-Meier fails and cumulative incidence succeeds when estimating failure probabilities in the presence of competing risks
Authors: Gooley, TA Leisenring, W Crowley, J Storer, BE
Citation: Ta. Gooley et al., Why Kaplan-Meier fails and cumulative incidence succeeds when estimating failure probabilities in the presence of competing risks, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 513-523
Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization
Authors: Disis, ML Schiffman, K Gooley, TA McNeel, DG Rinn, K Knutson, KL
Citation: Ml. Disis et al., Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization, CLIN CANC R, 6(4), 2000, pp. 1347-1350
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation
Authors: Chauncey, TR Gooley, TA Lloid, ME Schubert, MM Lilleby, K Holmberg, L Bensinger, WI
Citation: Tr. Chauncey et al., Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation, AM J CL ONC, 23(4), 2000, pp. 406-411
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age
Authors: Deeg, HJ Shulman, HM Anderson, JE Bryant, EM Gooley, TA Slattery, JT Anasetti, C Fefer, A Storb, R Appelbaum, FR
Citation: Hj. Deeg et al., Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age, BLOOD, 95(4), 2000, pp. 1188-1194
High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis
Authors: Souza, JP Boeckh, M Gooley, TA Flowers, MED Crawford, SW
Citation: Jp. Souza et al., High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis, CLIN INF D, 29(6), 1999, pp. 1467-1471
Estimation of failure probabilities in the presence of competing risks: New representations of old estimators
Authors: Gooley, TA Leisenring, W Crowley, J Storer, BE
Citation: Ta. Gooley et al., Estimation of failure probabilities in the presence of competing risks: New representations of old estimators, STAT MED, 18(6), 1999, pp. 695-706
Risultati: 1-11 |